Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor delta subunit-containing receptor (delta-GABAAR) (delta-GABAAR)

Target
delta-GABAAR
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop receptor family
01

Overview

Extrasynaptic delta-containing GABA-A receptors are a specialized subclass of ligand-gated ion channels located outside the synaptic cleft, typically composed of alpha-4 or alpha-6, beta, and delta subunits (Brickley & Mody, 2012, Nature Reviews Neuroscience). Unlike synaptic receptors that mediate rapid phasic inhibition, these receptors respond to low concentrations of ambient GABA to provide a persistent tonic inhibitory current that regulates the baseline excitability of neurons (Belelli et al., 2009, Journal of Neuroscience). They are uniquely sensitive to endogenous neurosteroids, such as allopregnanolone, which act as potent positive allosteric modulators (Maguire & Mody, 2008, Neuron). This sensitivity makes them critical in the pathophysiology of mood disorders, particularly postpartum depression, where neurosteroid levels fluctuate significantly (Meltzer-Brody et al., 2018, The Lancet). Pharmacological targeting of these receptors with synthetic neurosteroids like brexanolone and zuranolone has proven effective in treating depressive symptoms by restoring inhibitory tone (Gunduz-Bruce et al., 2019, NEJM). Additionally, these receptors are implicated in epilepsy and alcohol use disorders, serving as a distinct therapeutic target from traditional benzodiazepine-sensitive synaptic GABA-A receptors (Whiting, 2003, Drug Discovery Today).

Other names
Extrasynaptic delta-containing GABA-A receptorsdelta-GABAARsGABRD-containing receptorsTonic GABA-A receptorsExtrasynaptic GABA-A receptors
02

Mechanism of action

Positive allosteric modulation of extrasynaptic GABA-A receptors to enhance tonic chloride conductance and reduce neuronal over-excitability.

03

Biological functions

Tonic inhibitionNeuronal excitability regulationSignal transductionSynaptic plasticity
04

Disease associations

Postpartum depressionMajor depressive disorderEpilepsyInsomniaAlcohol use disorderFragile X syndromePremenstrual dysphoric disorder
05

Safety considerations

SedationSomnolenceDizzinessRisk of sudden loss of consciousnessPotential for abuse
06

Interacting drugs

Brexanolone

5 more in the full profile.

07

Biomarkers

EEG power spectra (beta and gamma bands)Allopregnanolone plasma levels

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor delta subunit-containing receptor (delta-GABAAR) (delta-GABAAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor delta subunit-containing receptor (delta-GABAAR) (delta-GABAAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call